WHO ICTRP trial
Comparison of the human TNF-alpha antibody adalimumab with infliximab in…
EUCTR2008-004926-18-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-004926-18-DE |
|---|---|
| Public title | Comparison of the human TNF-alpha antibody adalimumab with infliximab in induction and maintenance of steroid-free remission in patients with moderate to severe Crohn’s disease - CHAMP |
| Scientific title | Comparison of the human TNF-alpha antibody adalimumab with infliximab in induction and maintenance of steroid-free remission in patients with moderate to severe Crohn’s disease - CHAMP |
| Primary sponsor | IBD Center LMU Munich |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Moderate to severe Crohn’s disease |
| Interventions | Trade Name: Humira Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous use Pharmaceutical form of the placebo: Solution for injection Route… |
| Registration date | Oct 30, 2008 |
| Secondary IDs | 00595 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: